{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:44:42Z","timestamp":1792262682352,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s11910-018-0839-1","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:43:22Z","timestamp":1525239802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["An Up to Date Review of Pseudotumor Cerebri Syndrome"],"prefix":"10.1007","volume":"18","author":[{"given":"John Glenn","family":"Burkett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ailani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"issue":"11","key":"839_CR1","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3174\/ajnr.A2404","volume":"32","author":"A Degnan","year":"2011","unstructured":"Degnan A, Levy L. Pseudotumor cerebri: brief review of clinical syndrome and imaging findings. Am J Neuroradiol. 2011;32(11):1986\u201393.","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"839_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/foc.2001.11.2.3","volume":"11","author":"I Johnston","year":"2001","unstructured":"Johnston I. The historical development of the pseudotumor concept. Neurosurg Focus. 2001;11(2):1\u20139.","journal-title":"Neurosurg Focus"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"D Friedman","year":"2013","unstructured":"Friedman D, Liu G, Digre K. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159\u201365.","journal-title":"Neurology"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/head.13236","volume":"58","author":"C Cleves-Bayon","year":"2017","unstructured":"Cleves-Bayon C. Idiopathic intracranial hypertension in children and adolescents: an update. Headache J Head Face Pain. 2017;58:485\u201393. \n                      https:\/\/doi.org\/10.1111\/head.13236\n                      \n                    .","journal-title":"Headache J Head Face Pain"},{"key":"839_CR5","doi-asserted-by":"publisher","unstructured":"Ekizoglu E. An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri. A\u011fr\u0131. 2015; \n                      https:\/\/doi.org\/10.5505\/agri.2015.22599\n                      \n                    .","DOI":"10.5505\/agri.2015.22599"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.0b013e31827debd6","volume":"80","author":"B Riggeal","year":"2012","unstructured":"Riggeal B, Bruce B, Saindane A, Ridha M, Kelly L, Newman N, et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology. 2012;80:289\u201395.","journal-title":"Neurology"},{"key":"839_CR7","first-page":"656","volume":"4","author":"A Rohr","year":"2007","unstructured":"Rohr A, D\u00f6rner L, Stingele R, Buhl R, Alfke K, Jansen O. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2007;4:656\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2015-311302","volume":"87","author":"S Mollan","year":"2016","unstructured":"\u2022 Mollan S, Ali F, Hassan-Smith G, Botfield H, Friedman D, Sinclair A. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87:982\u201392. Recent review of PTCS pathophysiology and treatment trials.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/WNO.0b013e31815b9af0","volume":"27","author":"J Warner","year":"2007","unstructured":"Warner J, Larson A, Bhosale P, Digre K, Henley C, Alder S, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol. 2007;27:258\u201362.","journal-title":"J Neuroophthalmol"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1212\/01.WNL.0000163556.31080.98","volume":"64","author":"A Tabassi","year":"2005","unstructured":"Tabassi A, Salmasi A, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology. 2005;64:1893\u20136.","journal-title":"Neurology"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jns.2016.11.014","volume":"372","author":"J Libien","year":"2017","unstructured":"\u2022 Libien J, Kupersmith M, Blaner W, McDermott M, Gao S, Liu Y, et al. Role of vitamin A metabolism in IIH: results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci. 2017;372:78\u201384. Vitamin A metabolite levels in patients of the Idiopathic Intracranial Hypertension Treatment Trial.","journal-title":"J Neurol Sci"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/WNO.0000000000000448","volume":"37","author":"S Subramaniam","year":"2017","unstructured":"\u2022 Subramaniam S, Fletcher W. Obesity and weight loss in idiopathic intracranial hypertension. J Neuroophthalmol. 2017;37:197\u2013205. Recent review of published literature regarding the association of PTCS and obesity.","journal-title":"J Neuroophthalmol"},{"issue":"3","key":"839_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00701-016-3050-7","volume":"159","author":"M Portelli","year":"2016","unstructured":"Portelli M, Papageorgiou P. An update on idiopathic intracranial hypertension. Acta Neurochir. 2016;159(3):491\u20139.","journal-title":"Acta Neurochir"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2017.01.006","volume":"124","author":"K Kilgore","year":"2017","unstructured":"Kilgore K, Lee M, Leavitt J, Mokri B, Hodge D, Frank R, et al. Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology. 2017;124:697\u2013700.","journal-title":"Ophthalmology"},{"key":"839_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jneuroim.2008.06.029","volume":"201-202","author":"A Sinclair","year":"2008","unstructured":"Sinclair A, Ball A, Burdon M, Clarke C, Stewart P, Curnow S, et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol. 2008;201-202:212\u201320.","journal-title":"J Neuroimmunol"},{"key":"839_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Sinclair AJ, Markey KA, Uldall M, Cato L, Miah M, Botfield H, et al. Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. J Pain Res 2016;9:223\u2013232. Review of PTCS\u2019 correlation with hormones and obesity.","DOI":"10.2147\/JPR.S80824"},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.2196\/resprot.7806","volume":"6","author":"K Markey","year":"2017","unstructured":"Markey K, Ottridge R, Mitchell J, Rick C, Woolley R, Ives N, et al. Assessing the efficacy and safety of an 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in the idiopathic intracranial hypertension drug trial, IIH:DT: clinical methods and Design for a Phase II randomized controlled trial. JMIR Res Protoc. 2017;6:e181.","journal-title":"JMIR Res Protoc"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.regpep.2010.05.009","volume":"164","author":"M Skau","year":"2010","unstructured":"Skau M, Goetze J, Rehfeld J, Jensen R. Natriuretic pro-peptides in idiopathic intracranial hypertension. Regul Pept. 2010;164:71\u20137.","journal-title":"Regul Pept"},{"key":"839_CR19","doi-asserted-by":"crossref","unstructured":"Ameli P, Madan M, Chigurupati S, Yu A, Chan S, Pattisapu J Effect of acetazolamide on aquaporin-1 and fluid flow in cultured choroid plexus. Acta Neurochir Suppl 2012;113:59\u201364.","DOI":"10.1007\/978-3-7091-0923-6_13"},{"issue":"1","key":"839_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0022-510X(93)90084-C","volume":"116","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Thacker A, Bohlaga N, Maloo J, Gerryo S. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993;116(1):18\u201328. (epidemiology)","journal-title":"J Neurol Sci"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1468-1331.2011.03372.x","volume":"18","author":"N Raoof","year":"2011","unstructured":"Raoof N, Sharrack B, Pepper I, Hickman S. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011;18:1266\u20138.","journal-title":"Eur J Neurol"},{"key":"839_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/ene.12442","volume":"21","author":"A Kesler","year":"2014","unstructured":"Kesler A, Stolovic N, Bluednikov Y, Shohat T. The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey. Eur J Neurol. 2014;21:1055\u20139.","journal-title":"Eur J Neurol"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/archdischild-2016-312238","volume":"102","author":"Y Matthews","year":"2017","unstructured":"\u2022\u2022 Matthews Y, Dean F, Lim M, Mclachlan K, Rigby A, Solanki G, et al. Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child. 2017;102:715\u201321. National prospective cohort study looking at 185 cases in the Britsh Paediatric Surveillance Unit.","journal-title":"Arch Dis Child"},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ane.12742","volume":"136","author":"A Sundholm","year":"2017","unstructured":"\u2022\u2022 Sundholm A, Burkill S, Sveinsson O, Piehl F, Bahmanyar S, Nilsson Remahl A. Population-based incidence and clinical characteristics of idiopathic intracranial hypertension. Acta Neurol Scand. 2017;136:427\u201333. (Obesity). Evaluation of the incidence of PTCS in Sweden using national patient registry.","journal-title":"Acta Neurol Scand"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","volume":"71","author":"M Wall","year":"2014","unstructured":"\u2022\u2022 Wall M, Kupersmith M, Kieburtz K, Corbett J, Feldon S, Friedman D, et al. The idiopathic intracranial hypertension treatment trial. JAMA Neurolgy. 2014;71:693. Outlines the baseline clinical characteristics of patients enrolled in the IIHTT\u2013701.","journal-title":"JAMA Neurolgy"},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1468-2982.1990.1006331.x","volume":"10","author":"M Wall","year":"1990","unstructured":"Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10:331\u20135.","journal-title":"Cephalalgia"},{"key":"839_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/head.13153","volume":"57","author":"D Friedman","year":"2017","unstructured":"\u2022\u2022 Friedman D, Quiros P, Subramanian P, Mejico L, Gao S, McDermott M, et al. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache J Head Face Pain. 2017;57:1195\u2013205. Findings from IIHTT regarding headache and PTCS.","journal-title":"Headache J Head Face Pain"},{"key":"839_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","volume":"68","author":"M Thambisetty","year":"2007","unstructured":"Thambisetty M, Lavin P, Newman N, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68:229\u201332.","journal-title":"Neurology"},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/lary.26581","volume":"128","author":"S Stevens","year":"2017","unstructured":"Stevens S, Rizk H, Golnik K, Andaluz N, Samy R, Meyer T, et al. Idiopathic intracranial hypertension: contemporary review and implications for the otolaryngologist. Laryngoscope. 2017;128:248\u201356.","journal-title":"Laryngoscope"},{"key":"839_CR30","first-page":"55","volume":"5","author":"JL Smith","year":"1985","unstructured":"Smith JL. Whence pseudotumor cerebri? J Clin Neuroopthalmol. 1985;5:55\u20136.","journal-title":"J Clin Neuroopthalmol"},{"key":"839_CR31","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/01.WNL.0000029570.69134.1B","volume":"59","author":"D Friedman","year":"2002","unstructured":"Friedman D, Jacobson D. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492\u20135.","journal-title":"Neurology"},{"key":"839_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.50.4.1094","volume":"50","author":"M Kupersmith","year":"1998","unstructured":"Kupersmith M, Gamell L, Turbin R, Peck V, Spiegel P, Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50:1094\u20138.","journal-title":"Neurology"},{"key":"839_CR33","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0161-6420(98)91234-9","volume":"105","author":"L Johnson","year":"1998","unstructured":"Johnson L, Krohel G, Madsen R, March G. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105:2313\u20137.","journal-title":"Ophthalmology"},{"key":"839_CR34","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.soard.2015.08.497","volume":"11","author":"J Handley","year":"2015","unstructured":"Handley J, Baruah B, Williams D, Horner M, Barry J, Stephens J. Bariatric surgery as a treatment for idiopathic intracranial hypertension: a systematic review. Surg Obes Relat Dis. 2015;11:1396\u2013403.","journal-title":"Surg Obes Relat Dis"},{"key":"839_CR35","doi-asserted-by":"publisher","first-page":"e017426","DOI":"10.1136\/bmjopen-2017-017426","volume":"7","author":"R Ottridge","year":"2017","unstructured":"\u2022 Ottridge R, Mollan S, Botfield H, et al. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the idiopathic intracranial hypertension weight trial (IIH:WT) protocol. BMJ Open. 2017;7:e017426. Ongoing trial comparing bariatric surgery vs. weight loss program for treatment of primary PTCS.","journal-title":"BMJ Open"},{"key":"839_CR36","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/head.13144","volume":"57","author":"S Smith","year":"2017","unstructured":"\u2022\u2022 Smith S, Friedman D. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache J Head Face Pain. 2017;57:1303\u201310. Review summarizing the results of the IIHTT since 2014.","journal-title":"Headache J Head Face Pain"},{"key":"839_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-012-0207-4","volume":"15","author":"M Thurtell","year":"2012","unstructured":"Thurtell M, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol. 2012;15:1\u201312.","journal-title":"Curr Treat Options Neurol"},{"key":"839_CR38","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s00415-002-0791-4","volume":"249","author":"R Huna-Baron","year":"2002","unstructured":"Huna-Baron R, Kupersmith M. Idiopathic intracranial hypertension in pregnancy. J Neurol. 2002;249:1078\u201381.","journal-title":"J Neurol"},{"key":"839_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11910-014-0438-8","volume":"14","author":"N Mukherjee","year":"2014","unstructured":"Mukherjee N, Bhatti M. Update on the surgical management of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2014;14:438. \n                      https:\/\/doi.org\/10.1007\/s11910-014-0438-8\n                      \n                    .","journal-title":"Curr Neurol Neurosci Rep"},{"key":"839_CR40","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/bjophthalmol-2014-304953","volume":"98","author":"P Fonseca","year":"2014","unstructured":"Fonseca P, Rigamonti D, Miller N, Subramanian P. Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol. 2014;98:1360\u20133.","journal-title":"Br J Ophthalmol"},{"key":"839_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/02688697.2014.950633","volume":"29","author":"R deSouza","year":"2014","unstructured":"deSouza R, Toma A, Watkins L. Medication overuse headache\u2014an under-diagnosed problem in shunted idiopathic intracranial hypertension patients. Br J Neurosurg. 2014;29:30\u20134.","journal-title":"Br J Neurosurg"},{"key":"839_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/neurintsurg-2012-010468","volume":"5","author":"R Puffer","year":"2013","unstructured":"Puffer R, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J NeuroInterv Surg. 2013;5:483\u20136.","journal-title":"J NeuroInterv Surg"},{"key":"839_CR43","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3174\/ajnr.A4377","volume":"36","author":"S Satti","year":"2015","unstructured":"Satti S, Leishangthem L, Chaudry M. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. Am J Neuroradiol. 2015;36:1899\u2013904.","journal-title":"Am J Neuroradiol"},{"key":"839_CR44","unstructured":"(2018) 7.1.1 Headache attributed to idiopathic intracranial hypertension (IIH) - ICHD-3 The International Classification of Headache Disorders 3rd edition. In: ICHD-3 The International Classification of Headache Disorders 3rd edition. \n                      https:\/\/www.ichd-3.org\/7-headache-attributed-to-non-vascular-intracranial-disorder\/7-1-headache-attributed-to-increased-cerebrospinal-fluid-pressure\/7-1-1-headache-attributed-to-idiopathic-intracranial-hypertension-iih\/\n                      \n                    . Accessed 2 Apr 2018."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-018-0839-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T23:50:17Z","timestamp":1556754617000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-018-0839-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s11910-018-0839-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"2 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"John Glenn Burkett declares no potential conflicts of interest.Jessica Ailani has received: grant support from Allergan and Theranica, and honoraria from Allergan (advisory board, speaking), Alder (advisory board, speaking), Amgen (advisory board, speaking), Avanir (speaking), Eli Lily and company (advisory board, speaking), Electrocore (advisory board, speaking), Promius (advisory board, speaking), and Teva (advisory board, speaking).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"33"}}